Mercator Medical S.A. (WSE:MRC)
Poland · Delayed Price · Currency is PLN 51.20
-0.70 (-1.35%)
Jul 22, 2026, 1:12 PM CET
Mercator Medical Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 92.03 | 49.83 | -22.84 | -190.79 | 444.85 | 935.57 |
Depreciation & Amortization | 27.26 | 23.31 | 22.12 | 25.67 | 19.31 | 18.52 |
Other Adjustments | -101.36 | -63.95 | -61.06 | 179.41 | 2.67 | -1.02 |
Change in Receivables | 3.89 | -32.05 | -12.22 | 74.08 | 191.38 | -255.1 |
Changes in Inventories | -48.92 | -65.09 | 52.91 | 29.74 | -23.4 | -117.59 |
Changes in Accounts Payable | -16.46 | 25.63 | 17.16 | -41.99 | 6.55 | 148.23 |
Changes in Income Taxes Payable | -0.67 | -3.59 | -0.52 | -29.93 | -119.99 | -17.45 |
Changes in Other Operating Activities | -9.5 | -6.14 | 4.37 | -5.4 | -18.37 | 1.3 |
Operating Cash Flow | -53.73 | -72.06 | -0.09 | 40.79 | 503 | 712.47 |
Operating Cash Flow Growth | - | - | - | -91.89% | -29.40% | 1747.88% |
Capital Expenditures | -40.28 | -18.72 | -39.07 | -109.65 | -176.75 | -15.5 |
Sale of Property, Plant & Equipment | 1.01 | 0.66 | 0.62 | 0.35 | 0.16 | 0.97 |
Purchases of Investments | -82.01 | -156.44 | -90.69 | -170.25 | -398.55 | -146.97 |
Proceeds from Sale of Investments | 210.56 | 168.39 | 161.72 | 184.63 | 345.1 | 0.22 |
Other Investing Activities | -44.85 | -0.74 | 0 | -52.4 | - | - |
Investing Cash Flow | 44.43 | -6.84 | 33.59 | -146.74 | -230.05 | -161.27 |
Long-Term Debt Issued | 0.03 | 0 | 0 | 0.21 | 0 | 0 |
Long-Term Debt Repaid | -0 | -0.1 | -0.06 | 0 | -0.72 | -141.88 |
Net Long-Term Debt Issued (Repaid) | 0.03 | -0.1 | -0.06 | 0.21 | -0.72 | -141.88 |
Issuance of Common Stock | - | 0 | 0 | 0 | 0.75 | 0.27 |
Repurchase of Common Stock | -27.4 | -14.95 | -16.27 | 0 | -332.08 | -10.64 |
Net Common Stock Issued (Repurchased) | -27.4 | -14.95 | -16.27 | 0 | -331.34 | -10.37 |
Common Dividends Paid | - | 0 | -23.87 | 0 | 0 | -8.19 |
Other Financing Activities | -2.37 | -1.03 | -0.87 | -1.6 | -1.86 | -5.65 |
Financing Cash Flow | -29.74 | -16.08 | -41.07 | -1.39 | -333.91 | -166.09 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1.59 | 2.02 | 0.2 | -8.93 | 0.72 | -0.05 |
Net Cash Flow | -37.46 | -92.96 | -7.37 | -116.26 | -60.23 | 385.06 |
Free Cash Flow | -94.01 | -90.78 | -39.15 | -68.86 | 326.25 | 696.97 |
Free Cash Flow Growth | - | - | - | - | -53.19% | 2931.90% |
FCF Margin | -32.59% | -16.73% | -8.35% | -12.69% | 18.89% | 38.00% |
Free Cash Flow Per Share | -10.14 | -9.67 | -4.09 | -7.05 | 32.23 | 66.19 |
Levered Free Cash Flow | 2.97 | 6.34 | 37.22 | -320.97 | 133.5 | 805.82 |
Unlevered Free Cash Flow | -292.8 | 238.52 | 482.93 | -76.21 | 119.35 | 959.43 |